F. Stuart Foster

F. Stuart Foster

Auto-generated profile, based on publicly available information

F. Stuart Foster

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
FFF.STuart Foster
F.STuart Foster
CPCharles J Pavlin
Charles J Pavlin
KHKasia A Harasiewicz
Kasia A Harasiewicz
DCDonald A Christopher
Donald A Christopher
DTDaniel H Turnbull
Daniel H Turnbull

1 March 1991 in Ophthalmology
Verified
Journal Article
Closed access
CPCharles J. Pavlin
Charles J. Pavlin
KHKasia Harasiewicz
Kasia Harasiewicz
MSMichael D. Sherar
Michael D. Sherar
FFF. Stuart Foster
F. Stuart Foster

22 September 2006 in Science
Verified
Journal Article
Closed access
PDF file
YSYuval Shaked
Yuval Shaked
ACAlessia Ciarrocchi
Alessia Ciarrocchi
MFMarcela Franco
Marcela Franco
CLChristina R. Lee
Christina R. Lee
SMShan Man
Shan Man
RKRobert S. Kerbel
Robert S. Kerbel
The contribution of bone marrow–derived circulating endothelial progenitor cells (CEPs) to tumor angiogenesis has been controversial, primarily because of their low numbers in blood vessels of untreated tumors. We show that treatment of tumor-bearing mice with vascular disrupting agents (VDAs) leads to an acute mobilization of CEPs, which home to the viable tumor rim that characteristically remains after such therapy. Disruption of this CEP spike by antiangiogenic drugs or by genetic manipulation resulted in marked reductions in tumor rim size and blood flow as well as enhanced VDA antitumor activity. These findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.

1 April 1992 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CPCharles J. Pavlin
Charles J. Pavlin
KHKasia Harasiewicz
Kasia Harasiewicz
FFF. Stuart Foster
F. Stuart Foster

16 March 2014 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
MSMikhail G. Shapiro
Mikhail G. Shapiro
PGPatrick Goodwill
Patrick Goodwill
ANArkosnato Neogy
Arkosnato Neogy
MYMelissa Yin
Melissa Yin
FFF. Stuart Foster
F. Stuart Foster
SCSteven M. Conolly
Steven M. Conolly
Ultrasound is among the most widely used non-invasive imaging modalities in biomedicine1, but plays a surprisingly small role in molecular imaging due to a lack of suitable molecular reporters on the nanoscale. Here, we introduce a new class of reporters for ultrasound based on genetically encoded gas nanostructures from microorganisms, including bacteria and archaea. Gas vesicles are gas-filled protein-shelled compartments with typical widths of 45–250 nm and lengths of 100–600 nm that exclude water and are permeable to gas2,3. We show that gas vesicles produce stable ultrasound contrast that is readily detected in vitro and in vivo, that their genetically encoded physical properties enable multiple modes of imaging, and that contrast enhancement through aggregation permits their use as molecular biosensors.

1 February 1990 in Ophthalmology
Verified
Journal Article
Closed access
CPCharles J. Pavlin
Charles J. Pavlin
MSMichael D. Sherar
Michael D. Sherar
FFF. Stuart Foster
F. Stuart Foster